TG Therapeutics, Inc. ("TG" or "the Company"), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit ...
The DIRECT ANGIO randomised clinical trial by Benjamin Gory and colleagues1 in The Lancet Neurology was designed to test a biologically compelling premise: that a direct transfer to angiography suite ...
Simply copy and paste the embed code.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results